Total Payments
$4,351
2024 Payments
$1,237
Companies
27
Transactions
222
Medicare Patients
2,150
Medicare Billing
$611,747
Payment Breakdown by Category
Food & Beverage$4,271 (98.2%)
Education$80.16 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,271 | 217 | 98.2% |
| Education | $80.16 | 5 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $1,033 | 42 | $0 (2024) |
| Vifor Pharma, Inc. | $934.65 | 64 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $457.28 | 26 | $0 (2021) |
| Relypsa, Inc. | $438.83 | 33 | $0 (2020) |
| Medtronic USA, Inc. | $191.42 | 4 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $146.86 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $126.26 | 5 | $0 (2024) |
| Pulmonx Corporation | $122.98 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $121.97 | 1 | $0 (2017) |
| Amgen Inc. | $112.21 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,237 | 48 | Bayer Healthcare Pharmaceuticals Inc. ($587.65) |
| 2023 | $790.68 | 41 | Bayer Healthcare Pharmaceuticals Inc. ($297.67) |
| 2022 | $452.91 | 30 | Vifor Pharma, Inc. ($263.39) |
| 2021 | $310.21 | 23 | Vifor Pharma, Inc. ($214.61) |
| 2020 | $259.63 | 17 | Relypsa, Inc. ($148.84) |
| 2019 | $593.17 | 35 | Relypsa, Inc. ($208.56) |
| 2018 | $208.35 | 14 | OPKO Pharmaceuticals, LLC ($106.25) |
| 2017 | $499.40 | 14 | Medtronic USA, Inc. ($191.42) |
All Payment Transactions
222 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: Cardio-renal | ||||||
| 10/08/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Hyperkalemia | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $116.23 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: DIABETES | ||||||
| 09/06/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Hyperkalemia | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: Cardio-renal | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/11/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: NEPHROLOGY | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Cardio-renal | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: DIABETES | ||||||
| 08/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Cardiology | ||||||
| 07/25/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Hyperkalemia | ||||||
| 07/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardio-renal | ||||||
| 07/08/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Nephrology | ||||||
| 07/02/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Hyperkalemia | ||||||
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 509 | 1,209 | $285,195 | $130,620 |
| 2022 | 12 | 498 | 1,233 | $302,805 | $142,874 |
| 2021 | 11 | 589 | 1,465 | $372,725 | $179,791 |
| 2020 | 9 | 554 | 1,471 | $416,180 | $158,462 |
Total Patients
2,150
Total Services
5,378
Medicare Billing
$611,747
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 27 | 148 | $88,800 | $37,398 | 42.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 115 | $57,500 | $23,364 | 40.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 285 | $31,350 | $17,311 | 55.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 83 | 101 | $28,280 | $13,453 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 212 | $22,260 | $12,191 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 101 | $14,645 | $8,154 | 55.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 84 | $12,600 | $7,677 | 60.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 25 | 95 | $19,000 | $5,212 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $8,800 | $4,830 | 54.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 28 | $1,960 | $1,030 | 52.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 32 | 173 | $103,800 | $46,787 | 45.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 28 | 133 | $66,500 | $29,826 | 44.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 305 | $33,550 | $16,815 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 236 | $24,780 | $13,630 | 55.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 64 | 76 | $21,280 | $11,628 | 54.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 93 | $13,485 | $7,911 | 58.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 27 | 92 | $18,400 | $5,209 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $7,920 | $4,316 | 54.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 43 | $6,450 | $3,413 | 52.9% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 12 | 12 | $3,600 | $1,904 | 52.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,430 | $747.24 | 52.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 23 | $1,610 | $688.09 | 42.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 39 | 229 | $137,400 | $63,942 | 46.5% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 31 | 120 | $60,000 | $27,960 | 46.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 90 | 132 | $36,960 | $20,510 | 55.5% |
About Dr. Vincent Bobby, DO
Dr. Vincent Bobby, DO is a Nephrology healthcare provider based in Hazle Township, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811962780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Bobby, DO has received a total of $4,351 in payments from pharmaceutical and medical device companies, with $1,237 received in 2024. These payments were reported across 222 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,271).
As a Medicare-enrolled provider, Bobby has provided services to 2,150 Medicare beneficiaries, totaling 5,378 services with total Medicare billing of $611,747. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Hazle Township, PA
- Active Since 02/22/2006
- Last Updated 10/19/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811962780
Products in Payments
- Veltassa (Drug) $1,138
- Kerendia (Drug) $1,033
- Rayaldee (Drug) $319.26
- JARDIANCE (Drug) $203.45
- INTERSTIM (Device) $191.42
- RAYALDEE (Drug) $122.99
- CHARTIS CATHETER (Device) $122.98
- ENTRESTO (Drug) $121.97
- Korsuva (Drug) $97.87
- ACTHAR (Biological) $90.57
- IBSRELA (Drug) $81.61
- FARXIGA (Drug) $75.79
- LOKELMA (Drug) $71.07
- SOLIRIS (Drug) $65.04
- TARPEYO (Drug) $60.22
- JYNARQUE (Drug) $55.62
- Parsabiv (Biological) $47.69
- INVOKANA (Drug) $33.17
- Vascepa (Drug) $31.43
- Auryxia (Drug) $30.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.